News

Preliminary data from clinical trials of tecovirimat as a treatment for mpox virus infection have given disappointing results ...
Positive EMA Scientific Advice Positions GeoVax for Expedited European Approval ATLANTA, GA - July 21, 2025 (NEWMEDIAWIRE) - ...
Health officials have confirmed a case of Mpox in Brisbane’s south region, with tests confirming the strain is only the ...
To harness the power of AI for global health, institutional funders and governments need to adopt four key principles.
KINSHASA, Democratic Republic of the Congo, July 19, 2025/APO Group/ -- Mpox continues to strain the Democratic Republic of the Congo's health sys ...
European regulators on Friday said that the Duchenne muscular dystrophy gene therapy Elevidys should not be approved ...
The expiration of shots the Biden administration promised to send comes after President Donald Trump cut deeply into foreign aid.
As the world was grappling with the aftermath of COVID-19, a sudden Mpox outbreak between 2022 and 2023 caught global health systems off guard. What began in remote villages and mining regions of the ...
SHELTON, CT / ACCESS Newswire / July 21, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the ...
COPENHAGEN, Denmark, July 24, 2025 - Bavarian Nordic A/S (OMX: BAVA) has become aware of market rumours regarding a potential takeover offer for Bavarian Nordic A/S by a consortium consisting of Nordi ...
Chikungunya is a mosquito-borne viral disease that causes fever and severe joint pain, which is often debilitating. In some cases it can be deadly.
Bavarian Nordic A/S (OMX: BAVA) announced today that Health Canada has accepted for review the Company’s application for ...